Purchase Order 75F40123P00306

Award Date 8/24/23
Potential Completion Date 11/22/23
Potential Value $48K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Walkersville, MD 21793, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
5
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Lonza Walkersville, Inc. has been awarded a firm fixed price purchase order totaling $27,560.40 by the Department of Health and Human Services' National Institutes of Health Clinical Center. The contract calls for the delivery of Hanks' Balanced Salt Solution to the agency's facility in Walkersville, Maryland by February 29, 2024. Lonza Walkersville is a manufacturer located in Walkersville and currently holds a $10 million Blanket Purchase Agreement with NIH to provide biological materials,...
This is a firm fixed-price purchase order valued at $9,947.51, awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Lonza Walkersville, Inc. for Nucleofector laboratory equipment. The contract has a completion date of September 5, 2014 and was awarded on August 27, 2014. Lonza Walkersville is a subsidiary of Lonza Group Ltd., a global life sciences company, and is a leading provider of specialized biological...
This federal contract award to Lonza Walkersville, Inc. Walkersville Division, a subsidiary of the global company Lonza Group Ltd., is for the supply of Biopredic International NoSpin HepaRG cells to the Food and Drug Administration (FDA). The $40,666.00 firm-fixed-price purchase order is to support research at the National Center for Toxicological Research (NCTR) on the cytotoxicity and genotoxicity of small-molecule nitrosamines and nitrosamine drug substance-related impurities. The key...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Lonza Walkersville, Inc., a subsidiary of Lonza Group Ltd. The $36,600 firm fixed-price purchase order is for the delivery of a 4D-Nucleofector X-Unit, a specialized laboratory instrument used for cell transfection research. The contract does not have a set-aside designation. Lonza Walkersville is a leading provider of...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Lonza Walkersville, Inc. The $17,328.00 award is for the delivery of specialized biological materials and laboratory equipment to support biomedical research and development activities at the NIH. Lonza Walkersville, a manufacturer of goods, has provided products such as Nucleofector systems, Cocoon automated cell therapy manufacturing platforms, cell culture media, and various...
This is a firm-fixed-price BPA call awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke to Lonza Walkersville, Inc., a for-profit manufacturer, for the provision of a 4D NUCLEOFECTOR CORE UNIT and 4D NUCLEOFECTOR X-UNIT. The work is to be performed at Lonza's Walkersville, Maryland facility. The potential value of this award is $24,220.01 and the completion date is December 31, 2024. This...
This contract was awarded by the Department of Health and Human Services National Institutes of Health Clinical Center to Lonza Walkersville, Inc., a for-profit manufacturer of biological materials, media products, laboratory supplies, and scientific equipment. The $11,643.50 firm-fixed-price contract is a Blanket Purchase Agreement (BPA) call to provide reagents needed by the NIH's Critical Care Medicine Department for research purposes. The contract has no set-aside designation and is...
This is a firm-fixed-price contract awarded by the National Cancer Institute, a component of the Department of Health and Human Services, to Lonza Walkersville, Inc. The $24,220.01 contract is for the delivery of 4D Nucleofector Core UNI equipment and related products. Lonza Walkersville is a for-profit manufacturer and supplier of specialized biological materials, laboratory equipment, and scientific services. This award is not set-aside and is a call against an existing Blanket Purchase...
This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS), to Lonza Walkersville, Inc., a subsidiary of Lonza Group Ltd. The $12,251.00 contract is for the delivery of a 4D Nucleofector Transfection System, a specialized laboratory equipment used for cell transfection in biomedical research. The contract does not have a set-aside designation. Lonza Walkersville is a...
This firm-fixed-price purchase order was awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, for the provision of a Luminex XMAP Intelliflex multiplexing magnetic bead-based plate reader system. The $85,350.06 contract includes delivery, installation, training, and one year of post-warranty preventative maintenance and repair services for the specialized laboratory equipment. The reader system will support the FDA's...

The Department of Health and Human Services Food and Drug Administration awarded a $47,660.83 firm fixed price purchase order to Lonza Walkersville, Inc. Walkersville Division. The contract is for the installation qualification (IQ/OQ/PQ) of an absorbance/fluorescence multimode microplate reader to support endotoxins testing. Performance will take place at the contractor's facility in Walkersville, Maryland over approximately three months concluding in November 2023. The original solicitation, referenced as seeking a 96-well absorbance/fluorescence multimode microplate reader, indicates the equipment will support the FDA's evaluation of medical product safety and quality. No subcontractors or additional context was provided.

Generated 12/20/23, 4:13 AM